首页> 外国专利> METHOD OF OBJECTIFYING INDICATIONS FOR CHOOSING TREATMENT FOR PATIENTS WITH ULCER DISEASE IN COMBINATION WITH ARTERY HYPERTENSION

METHOD OF OBJECTIFYING INDICATIONS FOR CHOOSING TREATMENT FOR PATIENTS WITH ULCER DISEASE IN COMBINATION WITH ARTERY HYPERTENSION

机译:溃疡病合并动脉高压的患者选择适应症的治疗方法

摘要

FIELD: medicine.;SUBSTANCE: invention relates to medicine, in particular to gastroenterology and cardiology and concerns method of objectifying indications for choosing treatment of patients with ulcer disease (UD) in combination with artery hypertension (AH). For this purpose in accordance with WHO/ISAH classification of 1999, degree of AH and risk of development of cardio-vascular complications (RDCVC) is determined for patients. Patients with UD in combination with AH of I degree and RDCVC of 1-4 degree, as well as patients with UD with AH of II degree and RDCVC of 2 degree undergo traditional anti-ulcer and conventional hypertension therapy. Patients with UD and AH of II degree and RDCVC of 3-4 degree and patients with UD and AH of III degree and RDCVC of 4 degree are examined for presence of immune disorders, intestine disbacteriosis, depressive disorders, sympaticotonia, metabolic syndrome. If said disorders are found immunomodulators, antidepressants, vegetotropic medications are administered and metabolic syndrome therapy is performed, as hypotensive medications ACE inhibitors are introduced. Patients with UD with AH of III degree and RDCVC of 4 degree are administered combined therapy with ACE inhibitors and pulse slowing calcium antagonists, excluding preparations with make QT interval longer.;EFFECT: method ensures individualised treatment of said category of patients taking into account unfavourable development of ulcerous process depending on expression of systemic microcirculation disorders, determined by AH and RDCVC degree, which allows to influence different links of pathologic process fully and prevent development of complications.;8 tbl, 2 ex
机译:发明领域本发明涉及医学,尤其涉及肠胃病学和心脏病学,并且涉及针对选择溃疡性疾病(UD)并伴有动脉高血压(AH)的患者的治疗的客观适应症的方法。为此,根据1999年WHO / ISAH分类,确定患者的AH程度和发生心血管并发症的风险(RDCVC)。 UD合并I度AH和1-4度RDCVC的UD患者,以及Ⅱ度AH和2度RDCVC的UD患者接受传统的抗溃疡和常规高血压治疗。检查患有Ⅱ度UD和AH且3-4度的RDCVC的患者以及患有Ⅲ度UD和AH且4度的RDCVC的患者是否存在免疫疾病,肠细菌性疾病,抑郁症,交感神经紧张,代谢综合征。如果发现上述疾病,可以使用免疫调节剂,抗抑郁药,素食药并进行代谢综合症治疗,因为引入了降压药ACE抑制剂。 AH为Ⅲ度AH且RDDCVC为4度的UD患者接受ACE抑制剂和脉搏减缓钙拮抗剂的联合治疗,不包括延长QT间隔的制剂。效果:方法考虑到不利因素,确保对上述类型的患者进行个体化治疗溃疡过程的发展取决于全身微循环障碍的表达,由AH和RDCVC程度决定,可以充分影响病理过程的不同环节并防止并发症的发展。[8 tbl,2 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号